There are several risks associated with the use of percutaneous AngioJet thrombectomy, none of which are common, but all of which require some knowledge of the issues to prevent complications.

Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...

SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...

Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe MARLBOROUGH, Mass., Boston Scientific has received United States (U.S.) Food and Drug Administration (FDA) approval ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific Corporation BSX recently won the U.S. Food and Drug Administration’s (FDA) approval and the CE Mark for its AngioJet ZelanteDVT thrombectomy catheter. The regulatory clearances make ...

Boston Scientific ($BSX) announced simultaneous approval to market its AngioJet ZelanteDVT thrombectomy catheter for treating deep vein thrombosis in the U.S., Europe ...

Patients diagnosed with mesenteric artery thrombosis (MAT), a rare and acute abdominal condition that has a fatality rate of about 70 percent, could now be better treated through the application of ...

Background A 43-year-old African-American female (gravida 5 para 0) with an 8-week intrauterine pregnancy presented to the emergency room with crampy abdominal pain, shortness of breath, and shoulder ...